Forte Biosciences, Inc. (FBRX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 19K | -45K | 17K | 15K | 13K | 10K | 10K | 10K | 9K | 6K | 3K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -19K | 45K | -17K | -15K | -13K | -10K | -10K | -10K | -9K | -6K | -3K | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -46.15% | 550% | -70% | -50% | -44.44% | -66.67% | -233.33% | - | - | - | - | - |
| Operating Expenses | 22.44M | 24.62M | 18.37M | 11.56M | 16.11M | 7.34M | 8.62M | 12.81M | 7.79M | 6.38M | 10.21M | 9.03M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.97M | 2.83M | 3.18M | 2.96M | 3.43M | 2.11M | 2.76M | 7.08M | 3.44M | 2.81M | 3.85M | 1.9M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 20.32M | 21.44M | 15.05M | 8.62M | 12.54M | 5.23M | 5.72M | 5.74M | 4.35M | 3.57M | 6.37M | 7.14M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 150K | 345K | 150K | 0 | 150K | 0 | 150K | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.44M | -24.57M | -18.38M | -11.58M | -16.12M | -7.35M | -8.63M | -12.82M | -7.8M | -6.38M | -10.22M | -9.03M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -39.17% | -234.25% | -113.04% | 9.67% | -106.61% | -15.2% | 15.53% | -41.89% | -13.84% | -29.2% | -198.45% | -199.14% |
| EBITDA | -22.42M | -24.55M | -18.37M | -11.56M | -16.11M | -7.34M | -8.62M | -12.81M | -7.79M | -6.38M | -10.21M | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -39.16% | -234.45% | -113.09% | 9.71% | -106.68% | -15.15% | 15.61% | - | -15.43% | -29.31% | -200.38% | 100% |
| D&A (Non-Cash Add-back) | 19K | 19K | 17K | 15K | 13K | 10K | 10K | 10K | 9K | 6K | 3K | 9.03M |
| EBIT | -22.44M | -24.57M | -17.68M | -11.58M | -16.12M | -7.16M | -8.63M | -12.82M | -7.8M | -7M | -10.22M | -9.03M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 1.31M | 0 | 0 | 0 | 1.02M | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 1.31M | 0 | 0 | 0 | 1.12M | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102K | 0 | 0 |
| Other Income/Expense | 676K | 820K | 701K | 330K | 468K | 196K | 237K | 307K | 384K | 509K | 261K | 138K |
| Pretax Income | -21.76M | -23.75M | -17.68M | -11.25M | -15.66M | -7.16M | -8.39M | -12.51M | -7.42M | -5.87M | -9.96M | -8.9M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 373K | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -1.71% | -4.37% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -22.14M | -24.79M | -17.68M | -11.25M | -15.66M | -7.16M | -8.39M | -12.51M | -7.42M | -5.87M | -9.96M | -8.9M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -41.39% | -246.44% | -110.7% | 10.09% | -111% | -21.85% | 15.7% | -40.64% | -9.88% | -20.25% | -192.79% | -191.67% |
| Net Income (Continuing) | -22.14M | -24.79M | -17.68M | -11.25M | -15.66M | -7.16M | -8.39M | -12.51M | -7.42M | -5.87M | -9.96M | -8.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.24 | -1.39 | -0.99 | -0.96 | -1.37 | -1.12 | -4.54 | -6.78 | -4.77 | -4.04 | -6.57 | -10.57 |
| EPS Growth % | 9.49% | -24.11% | 78.19% | 85.84% | 71.28% | 72.28% | 30.93% | 35.84% | 40.65% | 30.41% | -46.37% | -105.58% |
| EPS (Basic) | -1.24 | -1.39 | -0.99 | -0.96 | -1.37 | -1.12 | -4.54 | -6.78 | -4.77 | -4.04 | -6.57 | -10.57 |
| Diluted Shares Outstanding | 178.37M | 147.18M | 17.79M | 11.74M | 11.4M | 6.39M | 1.85M | 1.85M | 1.55M | 1.45M | 1.51M | 841.87K |
| Basic Shares Outstanding | 178.37M | 147.18M | 17.79M | 11.74M | 11.4M | 6.39M | 1.85M | 1.85M | 1.55M | 1.45M | 1.51M | 841.87K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |